BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:177Lu-DPI-4452 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of 177Lu-DPI-4452\, from ClinicalTrials.gov 
 estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT05706129-2302@assetmemo.bio
DTSTAMP:20261121T005717Z
DTSTART;VALUE=DATE:20270630
DTEND;VALUE=DATE:20270701
SUMMARY:177Lu-DPI-4452: Phase 1/2 readout est. (NCT05706129)
DESCRIPTION:177Lu-DPI-4452\, phase 1/2\, Non-Small Cell Lung Cancer.\nStudy
 : A Study to Assess Safety\, Tolerability and Imaging Characteristics of [
 68Ga]Ga-DPI-4452 and to Assess Safety\, Tolerability\, and Efficacy of [17
 7Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Meta
 static Solid Tumors\nEstimated primary completion: June 2027. This is a Cl
 inicalTrials.gov estimate\, not a confirmed readout date\, and it can move
 .\nDrug page: https://assetmemo.bio/drug/177lu-dpi-4452#upcoming-events\nR
 egistry record: https://clinicaltrials.gov/study/NCT05706129
URL:https://assetmemo.bio/drug/177lu-dpi-4452#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
